Could GLP-1 Agonists Offer a New Approach to Hidradenitis Suppurativa?
Hidradenitis Suppurativa (HS) is a challenging inflammatory skin condition often linked to obesity and metabolic dysfunction. With GLP-1 agonists gaining attention for weight loss and glycemic control, could they also help reduce HS severity? This letter reviews existing reports on GLP-1 agonists in HS treatment, exploring their potential role in reducing inflammation and disease burden.
